In Vitro ADME / DMPK CROs in India
8 published
8 published CROs match In Vitro ADME / DMPK in India.
Facilities in this set are in Bengaluru, Hyderabad, Ankleshwar, Jaipur, Mallapur, and New Delhi.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Cell Therapy, Gene Therapy, and Vaccine.
Matching companies
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Biolivz Research Center Private LimitedBiolivz Research Center is a preclinical contract research organization in Telangana, India. It offers in vitro ADME, in vivo pharmacokinetics and toxicokinetics, bioanalysis, in vivo pharmacology, and strategic services to drug development clients.
Novick BiosciencesOverview Novick Biosciences describes itself as a strategic research partner for pharmaceutical companies, with a stated focus on flexible, innovative, and problem-solving models.
PI Health SciencesPI Health Sciences is an integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with R&D and manufacturing locations in Europe and India.
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
QPSQPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TheraIndx Lifesciences Pvt. Ltd.Bengaluru-based preclinical research partner offering hit-to-lead through preclinical development, with in vitro ADMET, in vivo PK/PD, advanced animal models with biomarkers, toxicology, and medicinal chemistry.
Markdown mirror: /services/in-vitro-admet/india.md